Nara Organics, a brand of organic baby formula, has issued a voluntary recall of its powdered infant formula after three infants who consumed the product were hospitalized with infant botulism. The recall was announced in a notice from the U.S.
Food and Drug Administration (FDA) on June 14, 2026.
The Centers for Disease Control and Prevention (CDC) confirmed that all three affected babies had been fed Nara Organics Powdered Infant Formula, which is sold exclusively at Target stores across the United States. The infants were located in California, Washington, and Pennsylvania, according to the FDA.
All three babies received successful treatment and no deaths have been reported.
The formula was not sold outside the United States. Although no lots of Nara Organics Powdered Infant Formula have tested positive for Clostridium botulinum—the bacterium that causes infant botulism—the company is voluntarily recalling all whole milk infant powdered formula products.
The three specific lots consumed by the sickened infants are 709125280E14F2, 709125288E14F2, and 708125174E14F2. These lot numbers can be found on the bottom of the formula cans.
In the FDA notice, Nara stated, "Nara is taking aggressive action to ensure the safety of the babies and families who use the product as we work closely with the FDA, Centers for Disease Control and Prevention (CDC), and state partners to support their investigation into the root causes of these cases."
Customers are urged to stop using the affected products immediately. Those who purchased formula from Nara.com between May and June 2026 will receive an automatic refund.
Others who bought it from Nara.com can request a refund online. Consumers who purchased the product at Target should return it there or visit Target's website for a refund.
Infant botulism occurs when Clostridium botulinum spores enter and colonize the intestinal tract, leading to the growth of botulinum neurotoxins, according to the CDC. Symptoms in affected babies may include constipation, poor feeding, drooping eyelid, sluggish pupils, low muscle tone, difficulty sucking and swallowing, weak or altered crying, difficulty breathing, and generalized weakness.
Respiratory arrest is also possible, and the disease can be fatal. Caregivers should contact their healthcare provider immediately if a baby has consumed the product and begins showing these symptoms.
This recall follows a previous outbreak of infant botulism linked to the formula brand ByHeart, which caused over 50 illnesses across 19 states.